Skip to main content
SpringerLink
Log in

Reoperative Sentinel Lymph Node Biopsy: A New Frontier in the Management of Ipsilateral Breast Tumor Recurrence

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Breast conservation therapy (BCT) with sentinel lymph node (SLN) biopsy is a well-established standard of care for primary operable breast cancer; 5–10% of BCT patients will develop local recurrence (LR). The question then arises: How best to manage the axilla in the setting of LR after previous BCT and SLN biopsy or axillary dissection (ALND)?

Methods

Between 9/96 and 12/04, 117 reoperative SLN were performed for LR after BCT and either SLN biopsy or ALND more than 6 months previously. Because of wide variation in the number of nodes removed at the initial procedure, validation by backup ALND was not feasible in all cases.

Results

Reoperative SLN was successful in 64/117 (55%) patients. SLNs were identified by isotope and dye in 28/64 (44%); isotope only in 29/64 (45%); dye only in 4/64 (6%); 3/64 (5%) unknown. Positive reoperative SLN were found in 10/64 (16%) successful cases. Among 54/64 (84%) patients with negative reoperative SLNs, 23 (43%) had additional non-SLN removed concurrently: these were negative in 21/23 cases (91%). In 2/23 (9%), reoperative SLN were falsely negative: one with a positive intramammary node, and the other with a positive non-SLN palpated at surgery. Success of reoperative SLN was inversely related to number of nodes removed previously, and was more likely to be successful after a previous SLN biopsy than a previous ALND (74% vs. 38%, P = 0.0002). Non-axillary drainage was identified by lymphoscintigraphy significantly more often in reoperative SLN than in primary SLN biopsy (30% vs. 6%, P < 0.0001). There were no local or axillary recurrences at a mean follow up of 2.2 years; 6 patients developed systemic recurrence.

Conclusions

Reoperative SLN biopsy is feasible in the setting of LR after previous BCT/axillary surgery and deserves further study in this increasingly common clinical scenario. The added benefit of lymphoscintigraphy in identifying sites of non-axillary drainage may be greater in the setting of reoperative SLN than for the initial SLN procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Explore related subjects

Discover the latest articles, news and stories from top researchers in related subjects.

References

  1. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006; 106(1):4–16

    Article  PubMed  Google Scholar 

  2. Cody HS, 3rd. Sentinel lymph node biopsy for breast cancer: does anybody not need one? Ann Surg Oncol 2003; 10(10):1131–2

    Article  PubMed  Google Scholar 

  3. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23(30):7703–20

    Article  PubMed  Google Scholar 

  4. Port ER, Fey J, Gemignani ML, et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 2002; 195(2):167–72

    Article  PubMed  Google Scholar 

  5. National Comprehensive Cancer Network. Breast Cancer Screening and Diagnosis Guidelines. Clinical Practice Guidelines in Oncology v.1.2005, 2005. http://www.nccn.org/professionals/physician_gls/PDF/breast-screening.pdf

  6. Cody HS, 3rd, Borgen PI. State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol 1999; 8(2):85–91

    Article  PubMed  Google Scholar 

  7. Agarwal A, Heron DE, Sumkin J, Falk J. Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer. J Surg Oncol 2005 Oct 1;92(1):4–8

    Article  Google Scholar 

  8. Dinan D, Nagle CE, Pettinga J. Lymphatic mapping and sentinel node biopsy in women with an ipsilateral second breast carcinoma and a history of breast and axillary surgery. Am J Surg 2005; 190(4):614–7

    Article  PubMed  Google Scholar 

  9. Intra M, Trifiro G, Viale G, et al. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy. Ann Surg Oncol 2005; 12(11):895–9

    Article  PubMed  Google Scholar 

  10. Newman EA, Cimmino VM, Sabel MS, et al. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conserving therapy. Ann Surg Oncol 2006; 13(1):52–7

    Article  PubMed  Google Scholar 

  11. Taback B, Nguyen P, Hansen N, et al. Sentinel Lymph Node Biopsy for Local Recurrence of Breast Cancer after Breast Conserving Therapy. Ann Surg Oncol 2006 [E-pub only; in press]

  12. Burak WE, Jr., Walker MJ, Yee LD, et al. Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 1999; 177(6):445–9

    Article  PubMed  Google Scholar 

  13. Chagpar AB, Kehdy F, Scoggins CR, et al. Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. Am J Surg 2005; 190(4):557–62

    Article  PubMed  Google Scholar 

  14. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991; 338(8763):327–31

    Article  PubMed  CAS  Google Scholar 

  15. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 1995; 87(1):19–27

    Article  PubMed  CAS  Google Scholar 

  16. National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology v.2.2006. 2005. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp

  17. Schmoor C, Sauerbrei W, Bastert G, Schumacher M. Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. J Clin Oncol 2000; 18(8):1696–708

    PubMed  CAS  Google Scholar 

  18. van Tienhoven G, Voogd AC, Peterse JL, et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999; 35(1):32–8

    Article  PubMed  Google Scholar 

  19. Cody HS. Reoperative sentinel lymph node biopsy: adding nuance to the management of locally recurrent breast cancer. Ann Surg Oncol 2006. In press

  20. Silverstein MJ, Lagios MD, Martino S, et al. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol 1998; 16(4):1367–73

    PubMed  CAS  Google Scholar 

  21. Fortin A, Larochelle M, Laverdiere J, et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 1999; 17(1):101–9

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA

    Elisa Rush Port MD, Carlos A. Garcia-Etienne MD, Julia Park, Jane Fey MPH, Patrick I. Borgen MD & Hiram S. Cody III MD

  2. MRI-1026, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021

    Elisa Rush Port MD

Authors
  1. Elisa Rush Port MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos A. Garcia-Etienne MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Julia Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jane Fey MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Patrick I. Borgen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiram S. Cody III MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elisa Rush Port MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Port, E.R., Garcia-Etienne, C.A., Park, J. et al. Reoperative Sentinel Lymph Node Biopsy: A New Frontier in the Management of Ipsilateral Breast Tumor Recurrence. Ann Surg Oncol 14, 2209–2214 (2007). https://doi.org/10.1245/s10434-006-9237-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9237-z

Keywords

Search

Navigation